Apollomics
APLM
8 hedge funds and large institutions have $33.1M invested in Apollomics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.13% more ownership
Funds ownership: 0% → 0.13% (+0.13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GKFF
George Kaiser Family Foundation
Tulsa,
Oklahoma
|
+$18M |
| 2 |
O
OrbiMed
New York
|
+$17.8M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$359K |
| 4 |
JJ
Johnson & Johnson
New Brunswick,
New Jersey
|
+$356K |
| 5 |
CS
Clear Street
New York
|
+$182K |
Top Sellers
APLM Hedge Fund Activity: Q1 2023 in Review
8 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Apollomics (APLM) for Q1 2023, worth a combined $33.1M.
Buyers outnumbered sellers: 8 funds opened new APLM positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was George Kaiser Family Foundation, opening a new position worth an estimated $18M.
- 8 institutional investors held Apollomics (APLM) as of Q1 2023, up from 0 in Q4 2022.
- Funds reported $33.1M of Apollomics stock for Q1 2023.
- 8 funds opened new Apollomics positions in Q1 2023 and 0 closed out, a net change of +8 holders.
- The largest Apollomics buyer in Q1 2023 was George Kaiser Family Foundation, an estimated $18M added.
Based on aggregated 13F filings for Q1 2023.